PsyBio Therapeutics

Psy Bio Therapeutics

Biotechnology, Monroe Us, Coconut Creek, Florida, 45056, Louisiana, 71203, United States, 11-50 Employees

psybiolife.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 15*********

Who is PSYBIO THERAPEUTICS

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat...

Read More

map
  • Monroe Louisiana  71203 Us, Coconut Creek, Florida, 45056, United States Headquarters: Monroe Louisiana 71203 Us, Coconut Creek, Florida, 45056, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $500 Million to $1 Billion

industries-icon Industry: Biotechnology

SIC SIC Code: 3699 | NAICS Code: 551112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PSYBIO THERAPEUTICS

PsyBio Therapeutics Org Chart and Mapping

Employees

Michael Spigarelli

Chief Medical Officer and Chief Scientific Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PsyBio Therapeutics

Answer: PsyBio Therapeutics's headquarters are located at Monroe Us, Coconut Creek, Florida, 45056, Louisiana, 71203, United States

Answer: PsyBio Therapeutics's phone number is 15*********

Answer: PsyBio Therapeutics's official website is https://psybiolife.com

Answer: PsyBio Therapeutics's revenue is $500 Million to $1 Billion

Answer: PsyBio Therapeutics's SIC: 3699

Answer: PsyBio Therapeutics's NAICS: 551112

Answer: PsyBio Therapeutics has 11-50 employees

Answer: PsyBio Therapeutics is in Biotechnology

Answer: PsyBio Therapeutics contact info: Phone number: 15********* Website: https://psybiolife.com

Answer: PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy vs. Standard of care (SSRIs, SNRIs, MAOIs, NDRIs, etc...) which just chemically treat symptoms. Working in partnership with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants. TSXV: #PSYB OTCQB: #PSYBF

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access